SPONSOR
Institute of Cancer Research, United Kingdom
Total Trials
3
Recruiting
3
Phases
Phase 1
Conditions studied: High Grade Serous Ovarian CancerMalignant Primary GliomasGlioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-MutantGlioblastoma Multiforme (GBM)Multiple Myeloma
NCT06976892 Phase 1
Recruiting
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
High Grade Serous Ovarian Cancer
NCT06632236 Phase 1
Recruiting
5G-EMERALD: Amivantamab in Malignant Brain Tumours
Malignant Primary Gliomas
NCT05968417
Recruiting
Myeloma Novel Drug Discovery Ver 1.2
Multiple Myeloma